Shots: Arbutus discontinues its P-Ia/Ib study of AB-506 due to disappointing clinical findings i.e, observation of two cases of acute hepatitis in P-Ia clinical study assessing Ab-506 in healthy volunteers […]readmore
Tags : Clinical Study
Shots: Medtronic has initiated site recruitment for the Transforaminal Lumbar Interbody Fusion (TLIF) clinical study to enroll up to 50 sites with over 1,000 patients. The expanded indication to use […]readmore
Shots: The companies enter into a collaboration to identify genomic markers associated with clinical response to ADCT-402 (loncastuximab tesirine). ADC Therapeutics is currently assessing ADCT-402 in P-II study in patients […]readmore
Shots: The Center for iPS Cell Research and Application (CiRA) to transfer first T-CiRA cell therapy program to Takeda for its clinical development and the partners will continue to collaborate […]readmore
Shots: The study results involves assessing of CT-P13 SC (90mg/120mg/180mg) vs CT-P13 IV (3mg/kg) in 50 patients in ratio (1:1:1:1) with RA, followed by a P-I/III study assessing CT-P13 SC […]readmore
Shots: Innovate Biopharmaceuticals announces the initiation of P-III clinical study of INI-202 for Celiac disease with its expected screening & enrollment updates in next few months The P-III clinical study […]readmore
Shots: Neuclone plans for the onset of P-I clinical study for NeuLara, a Stelara’s biosimilar evaluating NeuLara vs the US & EU score of Stelara in healthy candidates in Australia […]readmore